A Multi-Site Study of the Zyga GlyDer Facet Restoration Device In Subjects With LUmbar FacET Pain Syndrome - DUET
- Conditions
- Facet Joint Pain
- Interventions
- Device: Glyder
- Registration Number
- NCT02179476
- Lead Sponsor
- Zyga Technology, Inc.
- Brief Summary
A non-randomized, multi-site feasibility study to evaluate the safety of the Glyder Device in subjects with a history of lumbar facet joint disease (L2 to the sacrum) and successful neural ablation in which the facet joint is confirmed as the source of pain.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 2
- Confirmed bilateral facet joint disease demonstrated by a successful facet rhizotomy (neural ablation) within 18 months prior to enrollment
- Facet pain is limited to one to two levels from L2 to the sacrum and pain is bilateral
- Two diagnostic injections (MBBs) both resulting in 80% relief to confirm back pain is facetogenic
- VAS back pain of ≥ 60 mm on a 100 mm scale, and VAS back pain is greater than or equal to the highest VAS leg pain score
- ODI ≥ 20 points
- At least six (6) months of non-operative conservative management (Analgesic therapy for a minimum of 2 weeks and a minimum of 4 weeks of NSAID therapy; Supervised exercise and/or physical therapy program-minimum of 12 sessions)
- At least 22 years of age and skeletally mature
Key
- Pain is from a spinal structure other than facet joints (i.e., disc, hip and SI joint pain are excluded)
- Osteoporosis or severe osteopenia
- Lumbar fusion
- Symptomatic spinal stenosis requiring surgical intervention
- Prior total disc replacement, fusion, decompressive laminectomy, facetectomy, or placement of a posterior spinous process device
- Disc herniation requiring surgical intervention
- The subject has a Body Mass Index (BMI) of greater than 35
- Planned elective surgery within 12 months
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Glyder Glyder Glyder Facet Restoration Device
- Primary Outcome Measures
Name Time Method Primary Safety Endpoint 6 months Safety will be evaluated by assessing the incidence of device and/or procedure related serious adverse events.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (4)
Laser Spine Institute
🇺🇸Tampa, Florida, United States
The Spine Institute
🇺🇸Santa Monica, California, United States
Clinical Radiology of Oklahoma
🇺🇸Edmond, Oklahoma, United States
Northwest Orthopaedic Specialists
🇺🇸Spokane, Washington, United States